Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.234
+0.001 (0.56%)
At close: Mar 9, 2026, 4:00 PM EDT
0.237
+0.003 (1.37%)
After-hours: Mar 9, 2026, 6:39 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $10.48 million as of March 9, 2026. Its market cap has decreased by -86.79% in one year.
Market Cap
10.48M
Enterprise Value
11.14M
1-Year Change
-86.79%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $10.48M, a decrease of -96.97%. That is a compound annual growth rate of -51.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.42M | -36.88% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 11.70M |
| Chemomab Therapeutics | 11.57M |
| CalciMedica | 11.45M |
| Akari Therapeutics, | 11.37M |
| Imunon | 11.02M |
| BiomX | 10.85M |
| Longeveron | 10.32M |
| Moleculin Biotech | 10.26M |